The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
EWS-FLI1 Utilizes Divergent Chromatin Remodeling Mechanisms to Directly Activate or Repress Enhancer Elements in Ewing Sarcoma
Open accessAbstract
Summary The aberrant transcription factor EWS-FLI1 drives Ewing sarcoma yet its molecular function is incompletely understood. We find that EWS-FLI1 reprograms gene regulatory circuits in Ewing sarcoma by directly inducing or repressing enhancers. At GGAA repeat elements, which lack evolutionary conservation and regulatory potential in other cell types, EWS-FLI1 multimers induce chromatin opening and create de novo enhancers that physically interact with target promoters. Conversely, EWS-FLI1 inactivates conserved enhancers containing canonical ETS motifs by displacing wild type ETS transcription factors. These divergent chromatin-remodeling patterns repress tumor suppressors and mesenchymal lineage regulators, while activating oncogenes and new potential therapeutic targets, such as the kinase VRK1. Our findings demonstrate how EWS-FLI1 establishes an oncogenic regulatory program governing both tumor survival and differentiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
An integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells
Mikkelsen, T. S., Ku, M., Jaffe, D. B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Brockman, W., Kim, T.-K., Koche, R. P., et al. (2007) · Nature · doi:10.1038/nature06008 · Cited by 4,129
Self-citationThe Polycomb complex PRC2 and its mark in life
Margueron, R., & Reinberg, D. (2011) · Nature · doi:10.1038/nature09784 · Cited by 3,347
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
The accessible chromatin landscape of the human genome
Thurman, R. E., Rynes, E., Humbert, R., Vierstra, J., Maurano, M. T., Haugen, E., Sheffield, N. C., Stergachis, A. B., Wang, H., Vernot, B., et al. (2012) · Nature · doi:10.1038/nature11232 · Cited by 2,679
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., et al. (2012) · Nature · doi:10.1038/nature10833 · Cited by 2,631
Chamberlain, G., Fox, J., Ashton, B., & Middleton, J. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0197 · Cited by 2,381
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907
Transcriptional Regulation and Its Misregulation in Disease
Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.014 · Cited by 1,620
A User's Guide to the Encyclopedia of DNA Elements (ENCODE)
The ENCODE Project Consortium (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001046 · Cited by 1,506
Genomewide Analysis of PRC1 and PRC2 Occupancy Identifies Two Classes of Bivalent Domains
Ku, M., Koche, R. P., Rheinbay, E., Mendenhall, E. M., Endoh, M., Mikkelsen, T. S., Presser, A., Nusbaum, C., Xie, X., Chi, A. S., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000242 · Cited by 1,009
Self-citationKaikkonen, M. U., Spann, N. J., Heinz, S., Romanoski, C. E., Allison, K. A., Stender, J. D., Chun, H. B., Tough, D. F., Prinjha, R. K., Benner, C., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.07.010 · Cited by 672
Genomic views of distant-acting enhancers
Visel, A., Rubin, E. M., & Pennacchio, L. A. (2009) · Nature · doi:10.1038/nature08451 · Cited by 610
Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo
Wei, G., Badis, G., Berger, M. F., Kivioja, T., Palin, K., Enge, M., Bonke, M., Jolma, A., Varjosalo, M., Gehrke, A. R., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.106 · Cited by 568 · cited 1×
“In addition, GGAA repeats were the most significant motif in recent binding studies for EWS-ERG (Wei et al., 2010), the second most common chromosomal translocation in Ewing sarcoma, suggesting that similar regulatory mechanisms are shared by Ewing tumors with less frequent fusion partners.”
BackgroundGenomic and biochemical insights into the specificity of ETS transcription factors
Hollenhorst, P. C., McIntosh, L. P., & Graves, B. J. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.79.081507.103945 · Cited by 490
Kadoch, C., & Crabtree, G. R. (2013) · Cell · doi:10.1016/j.cell.2013.02.036 · Cited by 484
Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice
Roberts, C. W. M., Galusha, S. A., McMenamin, M. E., Fletcher, C. D. M., & Orkin, S. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250492697 · Cited by 433
The super elongation complex (SEC) and MLL in development and disease
Smith, E., Lin, C., & Shilatifard, A. (2011) · Genes & Development · doi:10.1101/gad.2015411 · Cited by 361
Development of Ewing's Sarcoma from Primary Bone Marrow–Derived Mesenchymal Progenitor Cells
Riggi, N., Cironi, L., Provero, P., Suvà, M.-L., Kaloulis, K., Garcia-Echeverria, C., Hoffmann, F., Trumpp, A., & Stamenkovic, I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1696 · Cited by 359
Self-citationExpression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma
Smith, R., Owen, L. A., Trem, D. J., Wong, J. S., Whangbo, J. S., Golub, T. R., & Lessnick, S. L. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.004 · Cited by 351
Riggi, N., Suvà, M.-L., Suvà, D., Cironi, L., Provero, P., Tercier, S., Joseph, J.-M., Stehle, J.-C., Baumer, K., Kindler, V., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1761 · Cited by 332
Self-citationMicrosatellites as EWS/FLI response elements in Ewing's sarcoma
Gangwal, K., Sankar, S., Hollenhorst, P. C., Kinsey, M., Haroldsen, S. C., Shah, A. A., Boucher, K. M., Watkins, W. S., Jorde, L. B., Graves, B. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801073105 · Cited by 297 · cited 3×
“GGAA repeats have been implicated previously in Ewing sarcoma on the basis of their association with open chromatin and proximity to some activated genes (Gangwal et al., 2008; Guillon et al., 2009).”
BackgroundThe landscape of human STR variation
Willems, T., Gymrek, M., Highnam, G., The 1000 Genomes Project Consortium, Mittelman, D., & Erlich, Y. (2014) · Genome Research · doi:10.1101/gr.177774.114 · Cited by 283
Self-citationRiggi, N., & Stamenkovic, I. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.009 · Cited by 282
Self-citationRiggi, N., Suvà, M.-L., De Vito, C., Provero, P., Stehle, J.-C., Baumer, K., Cironi, L., Janiszewska, M., Petricevic, T., Suvà, D., et al. (2010) · Genes & Development · doi:10.1101/gad.1899710 · Cited by 279
Self-citationGuillon, N., Tirode, F., Boeva, V., Zynovyev, A., Barillot, E., & Delattre, O. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004932 · Cited by 218
Function of the Zinc-Finger Transcription Factor SNAI2 in Cancer and Development
Cobaleda, C., Pérez-Caro, M., Vicente-Dueñas, C., & Sánchez-García, I. (2007) · Annual Review of Genetics · doi:10.1146/annurev.genet.41.110306.130146 · Cited by 174
Functional Identification of Api5 as a Suppressor of E2F-Dependent Apoptosis In Vivo
Morris, E. J., Michaud, W. A., Ji, J., Moon, N.-S., Rocco, J. W., & Dyson, N. J. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020196 · Cited by 152
Di, C., Liao, S., Adamson, D. C., Parrett, T. J., Broderick, D. K., Shi, Q., Christoph Lengauer, C., Cummins, J. M., Velculescu, V. E., Fults, D. W., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.919.65.3 · Cited by 144
Zhang, Y., Xie, R., Gordon, J., LeBlanc, K., Stein, J. L., Lian, J. B., van Wijnen, A. J., & Stein, G. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.340398 · Cited by 123
Ewing tumor fusion proteins block the differentiation of pluripotent marrow stromal cells.
Torchia, E. C., Jaishankar, S., & Baker, S. J. (2003) · PubMed · Cited by 116
Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancerPreprint
Bilke, S., Schwentner, R., Yang, F., Kauer, M. O., Jug, G., Walker, R. L., Davis, S. R., Zhu, Y. J., Pineda, M. A., Meltzer, P. S., et al. (2013) · Genome Research · doi:10.1101/gr.151340.112 · Cited by 116
Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes
Duncan, C. G., Killela, P. J., Payne, C. A., Lampson, B. L., Chen, W., Liu, J., Solomon, D. A., Waldman, T. A., Towers, A. J., Gregory, S. G., et al. (2010) · Oncotarget · doi:10.18632/oncotarget.137 · Cited by 114
Roles of VRK1 as a new player in the control of biological processes required for cell division
Valbuena, A., Sanz-García, M., López-Sánchez, I., Vega, F. M. D. L., & Lazo, P. A. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.04.002 · Cited by 107
Ewing’s sarcoma precursors are highly enriched in embryonic osteochondrogenic progenitors
Tanaka, M., Yamazaki, Y., Kanno, Y., Igarashi, K., Aisaki, K., Kanno, J., & Nakamura, T. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72399 · Cited by 89
Wilms Tumor Chromatin Profiles Highlight Stem Cell Properties and a Renal Developmental Network
Aiden, A. P., Rivera, M. N., Rheinbay, E., Ku, M., Coffman, E. J., Truong, T. T., Vargas, S. O., Lander, E. S., Haber, D. A., & Bernstein, B. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.03.016 · Cited by 89
Self-citationControl of Tumorigenesis and Chemoresistance by the DEK Oncogene
Riveiro‐Falkenbach, E., & Soengas, M. S. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2330 · Cited by 84
Targeting the EWSR1-FLI1 Oncogene-Induced Protein Kinase PKC-β Abolishes Ewing Sarcoma Growth
Surdez, D., Benetkiewicz, M., Perrin, V., Han, Z., Pierron, G., Ballet, S., Lamoureux, F., Rédiní, F., Decouvelaere, A., Daudigeos‐Dubus, E., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0371 · Cited by 80
Vicente‐Dueñas, C., Romero-Camarero, I., González‐Herrero, I., Alonso-Escudero, E., Abollo‐Jiménez, F., Jiang, X., Gutierrez, N. C., Órfão, A., Marín, N., Villar, L. M., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.227 · Cited by 72
Emergent Properties of EWS/FLI Regulation via GGAA Microsatellites in Ewing's Sarcoma
Gangwal, K., Close, D., Enriquez, C. A., Hill, C. P., & Lessnick, S. L. (2010) · Genes & Cancer · doi:10.1177/1947601910361495 · Cited by 67
Rewiring of human lung cell lineage and mitotic networks in lung adenocarcinomas
Kim, I.-J., Quigley, D. A., To, M. D., Pham, P., Lin, K., Jo, B., Jen, K., Raz, D. J., Kim, J. H., Mao, J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2660 · Cited by 54
Müerköster, S. S., Rausch, A. V., Isberner, A., Minkenberg, J., Blaszczuk, E., Witt, M., Fölsch, U. R., Schmitz, F., Schäfer, H., & Arlt, A. (2007) · Oncogene · doi:10.1038/sj.onc.1210728 · Cited by 49
Molitor, T. P., & Traktman, P. (2013) · Oncogenesis · doi:10.1038/oncsis.2013.11 · Cited by 47
Beck, R. J., Monument, M. J., Watkins, W. S., Smith, R. A., Boucher, K. M., Schiffman, J. D., Jorde, L. B., Randall, R. L., & Lessnick, S. L. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.04.004 · Cited by 43
Role of protein–protein interactions in the antiapoptotic function of EWS-Fli-1
Ramakrishnan, R., Fujimura, Y., Zou, J.-P., Liu, F., Lee, L., Rao, V. N., & Reddy, E. S. P. (2004) · Oncogene · doi:10.1038/sj.onc.1207927 · Cited by 42
Sanchez, G., Delattre, O., Auboeuf, D., & Dutertre, M. (2008) · Cell Cycle · doi:10.4161/cc.6445 · Cited by 33
Cables1is a tumor suppressor gene that regulates intestinal tumor progression inApcMinmice
Arnason, T., Pino, M. S., Yilmaz, Ö. H., Kirley, S. D., Rueda, B. R., Chung, D. C., & Zukerberg, L. R. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.25089 · Cited by 25
Cited by
Grünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0003-x · Cited by 873
Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain
Boulay, G., Sandoval, G. J., Riggi, N., Iyer, S., Buisson, R., Naigles, B., Awad, M. E., Rengarajan, S., Volorio, A., McBride, M. J., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.036 · Cited by 470
Self-citationLiquid–liquid phase separation drives cellular function and dysfunction in cancer
Mehta, S., & Zhang, J. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00444-7 · Cited by 437
Mammalian SWI/SNF Chromatin Remodeling Complexes: Emerging Mechanisms and Therapeutic Strategies
Centore, R. C., Sandoval, G. J., Soares, L. M. M., Kadoch, C., & Chan, H. M. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.07.011 · Cited by 387
Riggi, N., Suvà, M. L., & Stamenkovic, I. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2028910 · Cited by 344
Self-citation
Metadata
- Authors
- Riggi, N., Knoechel, B., Gillespie, S. M., Rheinbay, E., Boulay, G., Suvà, M. L., Rossetti, N. E., Boonseng, W. E., Oksuz, O., Cook, E. B., Formey, A., Patel, A., Gymrek, M., Thapar, V., Deshpande, V., Ting, D. T., Hornicek, F. J., Nielsen, G. P., Stamenkovic, I., Aryee, M. J., Bernstein, B. E., & Rivera, M. N.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 26
- Issue
- 5
- Pages
- 668-681
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W1971516612
- Cited by
- 445
- References
- 49
- FWCI
- 19.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.